Oxbridge Re Holdings Limited (NASDAQ:OXBR) Short Interest Update

Oxbridge Re Holdings Limited (NASDAQ:OXBRGet Free Report) was the target of a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 113,543 shares, a growth of 343.9% from the July 30th total of 25,578 shares. Based on an average trading volume of 141,285 shares, the short-interest ratio is currently 0.8 days. Approximately 1.7% of the company’s shares are sold short.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on OXBR. Weiss Ratings raised Oxbridge Re from a “sell (d-)” rating to a “sell (d+)” rating in a research report on Friday, August 14th. Zacks Research downgraded shares of Oxbridge Re from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 18th. Finally, Maxim Group reduced their price target on shares of Oxbridge Re from $5.00 to $3.00 and set a “buy” rating on the stock in a research report on Tuesday, June 16th. One investment analyst has rated the stock with a Buy rating and two have given a Sell rating to the stock. According to MarketBeat, the company has a consensus rating of “Reduce” and an average target price of $3.00.

Check Out Our Latest Research Report on OXBR

Hedge Funds Weigh In On Oxbridge Re

Several hedge funds have recently modified their holdings of OXBR. J.W. Cole Advisors Inc. raised its position in Oxbridge Re by 106.1% in the fourth quarter. J.W. Cole Advisors Inc. now owns 68,000 shares of the insurance provider’s stock worth $90,000 after acquiring an additional 35,000 shares in the last quarter. International Assets Investment Management LLC lifted its position in shares of Oxbridge Re by 61.2% in the 1st quarter. International Assets Investment Management LLC now owns 48,000 shares of the insurance provider’s stock valued at $54,000 after acquiring an additional 18,227 shares in the last quarter. Finally, Virtu Financial LLC purchased a new stake in shares of Oxbridge Re in the third quarter valued at $32,000. 5.64% of the stock is currently owned by institutional investors and hedge funds.

Oxbridge Re Stock Performance

Shares of OXBR traded down $0.01 during midday trading on Wednesday, hitting $1.28. 301 shares of the stock traded hands, compared to its average volume of 287,840. Oxbridge Re has a 1-year low of $0.66 and a 1-year high of $2.86. The firm has a market capitalization of $10.46 million, a PE ratio of 64.28 and a beta of 1.94. The business’s 50 day moving average price is $1.34 and its two-hundred day moving average price is $1.08.

Oxbridge Re (NASDAQ:OXBRGet Free Report) last announced its quarterly earnings results on Thursday, August 13th. The insurance provider reported $0.02 EPS for the quarter, missing the consensus estimate of $0.03 by ($0.01). Oxbridge Re had a net margin of 4.71% and a return on equity of 2.14%. The firm had revenue of $0.94 million during the quarter, compared to analyst estimates of $1.10 million. As a group, equities research analysts forecast that Oxbridge Re will post -0.08 EPS for the current fiscal year.

Oxbridge Re Company Profile

(Get Free Report)

Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.

The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.

Further Reading

Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.